Erratum: Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs(PLoS ONE (2019) 14:5 (e0215607) DOI: 10.1371/journal.pone.0215607)

Abstract

The ORCID iD is missing for the corresponding author. The publisher apologizes for the error. Author Marcus A. Horwitz's ORCID iD is: 0000-0001-6525-7147 (https://orcid.org/ 0000-0001-6525-7147). In Table 2, Prothionamide was mistakenly abbreviated "PRS" instead of "PRO" in the second column, "Screening Test". Please see the corrected Table 2 here.